$970 Million is the total value of Logos Global Management LP's 66 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 75.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALXO | Sell | ALX ONCOLOGY HLDGS INC | $62,458,000 | -73.2% | 2,906,352 | -7.9% | 6.44% | -61.7% |
| CYTK | Buy | CYTOKINETICS INC | $60,394,000 | +69.0% | 1,325,000 | +32.5% | 6.23% | +141.7% |
| DSGN | DESIGN THERAPEUTICS INC | $59,359,000 | +45.7% | 2,772,501 | 0.0% | 6.12% | +108.4% | |
| BCYC | Sell | BICYCLE THERAPEUTICS PLCsponsored ads | $52,957,000 | -13.7% | 870,000 | -41.0% | 5.46% | +23.5% |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $47,280,000 | -1.1% | 1,000,000 | -31.0% | 4.88% | +41.5% |
| Buy | DICE THERAPEUTICS INC | $42,122,000 | +10.9% | 1,664,251 | +43.4% | 4.34% | +58.5% | |
| KRTX | Sell | KARUNA THERAPEUTICS INC | $39,300,000 | -30.2% | 300,000 | -34.8% | 4.05% | -0.1% |
| DYN | Sell | DYNE THERAPEUTICS INC | $38,457,000 | -34.6% | 3,234,392 | -10.6% | 3.97% | -6.4% |
| ALGS | Buy | ALIGOS THERAPEUTICS INC | $36,949,000 | +21.4% | 3,112,785 | +58.6% | 3.81% | +73.6% |
| IDYA | Sell | IDEAYA BIOSCIENCES INC | $36,642,000 | -19.0% | 1,550,000 | -12.7% | 3.78% | +15.8% |
| New | VENTYX BIOSCIENCES INC | $36,230,000 | – | 1,824,280 | +100.0% | 3.74% | – | |
| RPTX | Buy | REPARE THERAPEUTICS INC | $35,853,000 | +6729.1% | 1,700,000 | +8400.0% | 3.70% | +9631.6% |
| OLMA | OLEMA PHARMACEUTICALS INC | $35,043,000 | -66.0% | 3,743,875 | 0.0% | 3.61% | -51.4% | |
| KZR | Sell | KEZAR LIFE SCIENCES INC | $24,244,000 | -31.6% | 1,450,000 | -64.6% | 2.50% | -2.1% |
| FMTX | Sell | FORMA THERAPEUTICS HLDGS INC | $22,752,000 | -53.6% | 1,600,000 | -24.3% | 2.35% | -33.6% |
| GBT | New | GLOBAL BLOOD THERAPEUTICS IN | $21,953,000 | – | 750,000 | +100.0% | 2.26% | – |
| ISEE | New | IVERIC BIO INC | $21,736,000 | – | 1,300,000 | +100.0% | 2.24% | – |
| ATHA | Sell | ATHIRA PHARMA INC | $21,249,000 | +22.1% | 1,630,744 | -12.1% | 2.19% | +74.6% |
| VERV | VERVE THERAPEUTICS INC | $16,343,000 | -21.6% | 443,265 | 0.0% | 1.69% | +12.3% | |
| ALPN | Buy | ALPINE IMMUNE SCIENCES INC | $15,512,000 | +242.1% | 1,120,000 | +163.5% | 1.60% | +389.3% |
| HARP | New | HARPOON THERAPEUTICS INC | $14,572,000 | – | 1,930,000 | +100.0% | 1.50% | – |
| EWTX | Buy | EDGEWISE THERAPEUTICS INC | $12,988,000 | +20.8% | 850,000 | +24.7% | 1.34% | +72.9% |
| KYMR | New | KYMERA THERAPEUTICS INC | $12,698,000 | – | 200,000 | +100.0% | 1.31% | – |
| EPIX | Sell | ESSA PHARMA INC | $12,283,000 | +53.5% | 865,000 | -13.5% | 1.27% | +119.6% |
| FULC | New | FULCRUM THERAPEUTICS INC | $12,118,000 | – | 685,000 | +100.0% | 1.25% | – |
| JNCE | Sell | JOUNCE THERAPEUTICS INC | $11,273,000 | -24.1% | 1,350,000 | -32.5% | 1.16% | +8.5% |
| IPSC | Sell | CENTURY THERAPEUTICS INC | $9,739,000 | -39.4% | 614,095 | -3.9% | 1.00% | -13.4% |
| RLMD | New | RELMADA THERAPEUTICS INC | $9,012,000 | – | 400,000 | +100.0% | 0.93% | – |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $8,550,000 | – | 250,000 | +100.0% | 0.88% | – |
| NGM | New | NGM BIOPHARMACEUTICALS INC | $8,412,000 | – | 475,000 | +100.0% | 0.87% | – |
| MRTX | New | MIRATI THERAPEUTICS INC | $7,335,000 | – | 50,000 | +100.0% | 0.76% | – |
| FOLD | New | AMICUS THERAPEUTICS INC | $7,219,000 | – | 625,000 | +100.0% | 0.74% | – |
| Sell | TYRA BIOSCIENCES INC | $6,660,000 | -62.3% | 473,394 | -52.8% | 0.69% | -46.0% | |
| CMPS | Sell | COMPASS PATHWAYS PLCsponsored ads | $6,630,000 | -84.1% | 300,000 | -78.6% | 0.68% | -77.3% |
| LABP | Sell | LANDOS BIOPHARMA INC | $6,600,000 | -67.8% | 1,375,000 | -2.1% | 0.68% | -54.0% |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $5,935,000 | – | 35,000 | +100.0% | 0.61% | – |
| ELDN | ELEDON PHARMACEUTICALS INC | $5,908,000 | -28.6% | 1,339,793 | 0.0% | 0.61% | +2.0% | |
| ZGNX | New | ZOGENIX INC | $5,688,000 | – | 350,000 | +100.0% | 0.59% | – |
| FATE | New | FATE THERAPEUTICS INC | $5,500,000 | – | 94,000 | +100.0% | 0.57% | – |
| ARQT | New | ARCUTIS BIOTHERAPEUTICS INC | $5,185,000 | – | 250,000 | +100.0% | 0.54% | – |
| CNTA | Sell | CENTESSA PHARMACEUTICALS PLCsponsored ads | $5,118,000 | -71.3% | 454,545 | -57.5% | 0.53% | -59.0% |
| GRPH | Sell | GRAPHITE BIO INC | $5,050,000 | -74.5% | 406,308 | -66.3% | 0.52% | -63.5% |
| TALS | Sell | TALARIS THERAPEUTICS INC | $5,031,000 | -26.9% | 329,013 | -35.2% | 0.52% | +4.4% |
| SPRB | New | SPRUCE BIOSCIENCES INC | $4,906,000 | – | 1,100,000 | +100.0% | 0.51% | – |
| CGEM | CULLINAN ONCOLOGY INC | $4,450,000 | -31.6% | 288,458 | 0.0% | 0.46% | -2.1% | |
| YMAB | New | Y-MABS THERAPEUTICS INC | $4,053,000 | – | 250,000 | +100.0% | 0.42% | – |
| VTGN | New | VISTAGEN THERAPEUTICS INC | $3,900,000 | – | 2,000,000 | +100.0% | 0.40% | – |
| IKNA | IKENA ONCOLOGY INC | $3,760,000 | -0.6% | 299,853 | 0.0% | 0.39% | +42.1% | |
| JANX | Sell | JANUX THERAPEUTICS INC | $3,653,000 | -24.1% | 185,196 | -25.1% | 0.38% | +8.6% |
| RAIN | Sell | RAIN THERAPEUTICS INC | $3,158,000 | -52.2% | 245,161 | -47.3% | 0.33% | -31.7% |
| New | PYXIS ONCOLOGY INC | $3,144,000 | – | 286,652 | +100.0% | 0.32% | – | |
| TVTX | New | TRAVERE THERAPEUTICS INC | $3,104,000 | – | 100,000 | +100.0% | 0.32% | – |
| NUVALENT INC | $2,563,000 | -6.2% | 134,650 | 0.0% | 0.26% | +34.0% | ||
| New | LIANBIOsponsored ads | $2,543,000 | – | 412,837 | +100.0% | 0.26% | – | |
| WVE | New | WAVE LIFE SCIENCES LTD | $2,512,000 | – | 800,000 | +100.0% | 0.26% | – |
| SOMALOGIC INC | $2,333,000 | +4.3% | 200,493 | 0.0% | 0.24% | +49.7% | ||
| BMEA | Sell | BIOMEA FUSION INC | $1,879,000 | -77.6% | 252,320 | -64.1% | 0.19% | -68.0% |
| New | MARINUS PHARMACEUTICALS INC | $1,544,000 | – | 130,000 | +100.0% | 0.16% | – | |
| VERA | New | VERA THERAPEUTICS INCcl a | $1,336,000 | – | 50,000 | +100.0% | 0.14% | – |
| COGT | Sell | COGENT BIOSCIENCES INC | $1,287,000 | -83.5% | 150,000 | -83.8% | 0.13% | -76.3% |
| OMEGA THERAPEUTICS INC | $999,000 | -39.9% | 88,235 | 0.0% | 0.10% | -14.2% | ||
| VRNA | New | VERONA PHARMA PLCsponsored ads | $820,000 | – | 122,000 | +100.0% | 0.08% | – |
| DAWN | Sell | DAY ONE BIOPHARMACEUTICALS I | $624,000 | -77.7% | 37,069 | -28.8% | 0.06% | -68.3% |
| New | ADAGIO THERAPEUTICS INC | $508,000 | – | 70,000 | +100.0% | 0.05% | – | |
| NUVBWS | NUVATION BIO INC*w exp 07/07/202 | $126,000 | -28.8% | 66,666 | 0.0% | 0.01% | 0.0% | |
| MREO | MEREO BIOPHARMA GROUP PLCads | $75,000 | -34.2% | 46,984 | 0.0% | 0.01% | 0.0% | |
| KROS | Exit | KEROS THERAPEUTICS INC | $0 | – | -15,000 | -100.0% | -0.04% | – |
| GLUE | Exit | MONTE ROSA THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.08% | – |
| PASG | Exit | PASSAGE BIO INC | $0 | – | -125,010 | -100.0% | -0.09% | – |
| KNTE | Exit | KINNATE BIOPHARMA INC | $0 | – | -94,345 | -100.0% | -0.16% | – |
| STTK | Exit | SHATTUCK LABS INC | $0 | – | -200,000 | -100.0% | -0.29% | – |
| SYBX | Exit | SYNLOGIC INC | $0 | – | -1,500,000 | -100.0% | -0.33% | – |
| GHRS | Exit | GH RESEARCH PLCordinary shares | $0 | – | -324,333 | -100.0% | -0.46% | – |
| BCEL | Exit | ATRECA INC | $0 | – | -1,175,000 | -100.0% | -0.53% | – |
| ALT | Exit | ALTIMMUNE INC | $0 | – | -700,000 | -100.0% | -0.57% | – |
| IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -500,000 | -100.0% | -0.89% | – |
| PRLD | Exit | PRELUDE THERAPEUTICS INC | $0 | – | -400,000 | -100.0% | -0.90% | – |
| TIL | Exit | INSTIL BIO INC | $0 | – | -1,277,091 | -100.0% | -1.65% | – |
| VRDN | Exit | VIRIDIAN THERAPEUTICS INC | $0 | – | -1,500,000 | -100.0% | -1.78% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -510,000 | -100.0% | -2.19% | – |
| NKTX | Exit | NKARTA INC | $0 | – | -1,275,777 | -100.0% | -2.56% | – |
| PMVP | Exit | PMV PHARMACEUTICALS INC | $0 | – | -1,400,000 | -100.0% | -3.01% | – |
| DCPH | Exit | DECIPHERA PHARMACEUTICALS IN | $0 | – | -1,850,000 | -100.0% | -4.53% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 14 | Q3 2023 | 12.6% |
| KARUNA THERAPEUTICS INC | 14 | Q3 2023 | 5.6% |
| ALX ONCOLOGY HLDGS INC | 13 | Q3 2023 | 23.3% |
| DYNE THERAPEUTICS INC | 13 | Q3 2023 | 4.9% |
| APELLIS PHARMACEUTICALS INC | 12 | Q3 2023 | 12.4% |
| OLEMA PHARMACEUTICALS INC | 12 | Q3 2023 | 15.4% |
| DESIGN THERAPEUTICS INC | 11 | Q3 2023 | 8.0% |
| NUVATION BIO INC | 11 | Q3 2023 | 0.0% |
| BICYCLE THERAPEUTICS PLC | 10 | Q2 2023 | 5.7% |
| IDEAYA BIOSCIENCES INC | 9 | Q3 2023 | 9.5% |
View Logos Global Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | July 18, 2023 | 6,350,000 | 8.1% |
| BICYCLE THERAPEUTICS plc | February 14, 2023 | 1,435,000 | 4.8% |
| Dyne Therapeutics, Inc. | February 14, 2023 | 2,150,000 | 4.1% |
| Design Therapeutics, Inc. | March 31, 2022 | 2,797,501 | 5.0% |
| IDEAYA Biosciences, Inc. | March 18, 2022 | 2,650,000 | 6.9% |
| Aligos Therapeutics, Inc. | February 14, 2022 | ? | ? |
| Cogent Biosciences, Inc. | February 14, 2022 | 150,000 | 0.4% |
| Kezar Life Sciences, Inc. | February 14, 2022 | 1,450,000 | 3.0% |
| Nkarta, Inc. | February 14, 2022 | ? | ? |
| Viridian Therapeutics, Inc.\DE | February 14, 2022 | ? | ? |
View Logos Global Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-01 |
| SC 13G | 2024-02-22 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G | 2024-01-22 |
| SC 13G | 2024-01-22 |
| SC 13G | 2024-01-02 |
View Logos Global Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.